Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America LE Nicolle, K Gupta, SF Bradley, R Colgan, GP DeMuri, D Drekonja, ... Clinical Infectious Diseases 68 (10), e83-e110, 2019 | 933 | 2019 |
Preterm birth: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data JA Quinn, FM Munoz, B Gonik, L Frau, C Cutland, T Mallett-Moore, ... Vaccine 34 (49), 6047-6056, 2016 | 543 | 2016 |
Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm LO Eckert, SE Hawes, CE Stevens, LA Koutsky, DA Eschenbach, ... Obstetrics & Gynecology 92 (5), 757-765, 1998 | 405 | 1998 |
Physical injury after sexual assault: findings of a large case series NF Sugar, DN Fine, LO Eckert American journal of obstetrics and gynecology 190 (1), 71-76, 2004 | 307 | 2004 |
Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate‐to‐severe atopic dermatitis G Yosipovitch, M Reaney, V Mastey, L Eckert, A Abbé, L Nelson, M Clark, ... British Journal of Dermatology 181 (4), 761-769, 2019 | 268 | 2019 |
Endometritis: the clinical-pathologic syndrome LO Eckert, SE Hawes, PK Wölner-Hanssen, NB Kiviat, JN Wasserheit, ... American journal of obstetrics and gynecology 186 (4), 690-695, 2002 | 253 | 2002 |
Acute vulvovaginitis LO Eckert New England Journal of Medicine 355 (12), 1244-1252, 2006 | 224 | 2006 |
Impact of atopic dermatitis on health-related quality of life and productivity in adults in the United States: an analysis using the National Health and Wellness Survey L Eckert, S Gupta, C Amand, A Gadkari, P Mahajan, JM Gelfand Journal of the American Academy of Dermatology 77 (2), 274-279. e3, 2017 | 222 | 2017 |
Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real‐world analysis GH Lyman, L Eckert, Y Wang, H Wang, A Cohen The oncologist 18 (12), 1321-1329, 2013 | 216 | 2013 |
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape NI Mazur, J Terstappen, R Baral, A Bardají, P Beutels, UJ Buchholz, ... The Lancet Infectious Diseases 23 (1), e2-e21, 2023 | 213 | 2023 |
World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2–3 and screen‐and‐treat strategies to prevent cervical cancer N Santesso, RA Mustafa, HJ Schünemann, M Arbyn, PD Blumenthal, ... International Journal of Gynecology & Obstetrics 132 (3), 252-258, 2016 | 210 | 2016 |
SOLO 1 and SOLO 2 Investigators. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis EL Simpson, T Bieber, E Guttman-Yassky, LA Beck, A Blauvelt, MJ Cork, ... N Engl J Med 375 (24), 2335-2348, 2016 | 200 | 2016 |
HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women L Musey, Y Hu, L Eckert, M Christensen, T Karchmer, MJ McElrath The Journal of experimental medicine 185 (2), 293-304, 1997 | 175 | 1997 |
Relationship of Vaginal Bacteria and Inflammation With Conception and Early Pregnancy Loss Following In-Vitro Fertilization LO Eckert, DE Moore, DL Patton, KJ Agnew, DA Eschenbach Infectious diseases in obstetrics and gynecology 11 (1), 11-17, 2003 | 161 | 2003 |
Epidural analgesia and cesarean section for dystocia: Risk factors in Nulliparas PVM Thorp JA, Eckert LO, Ang MS, Peaceman AM Am J Perin 8, 402-10, 1991 | 160 | 1991 |
Efficacy and safety of multiple dupilumab dose regimens after initial successful treatment in patients with atopic dermatitis: a randomized clinical trial M Worm, EL Simpson, D Thaçi, R Bissonnette, JP Lacour, S Beissert, ... JAMA dermatology 156 (2), 131-143, 2020 | 158 | 2020 |
Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative) JR Chalmers, E Simpson, CJ Apfelbacher, KS Thomas, L Von Kobyletzki, ... British Journal of Dermatology 175 (1), 69-79, 2016 | 145 | 2016 |
Dupilumab in adolescents with uncontrolled moderate‐to‐severe atopic dermatitis: results from a phase IIa open‐label trial and subsequent phase III open‐label extension MJ Cork, D Thaçi, LF Eichenfield, PD Arkwright, T Hultsch, JD Davis, ... British Journal of Dermatology 182 (1), 85-96, 2020 | 142 | 2020 |
Comprehensive cervical cancer control: a guide to essential practice N Broutet, LO Eckert, A Ullrich, P Bloem World Health Organization, 1-378, 2014 | 139 | 2014 |
Common complementary and alternative therapies for yeast vaginitis and bacterial vaginosis: a systematic review K Van Kessel, N Assefi, J Marrazzo, L Eckert Obstetrical & gynecological survey 58 (5), 351-358, 2003 | 135 | 2003 |